Autonomix Medical(us:AMIX)
3.51
-2.50%
Updated on 2024-12-23
Open:3.57
Close:3.51
High:3.57
Low:3.38
Pre Close:3.60
Volume:41569.00
Amount:143159.31
Turnover:2.58%
Shares:1.61M
MarketCap:5.65M
| Date | Total | Total Shares | Total Ratio | New | Increased | Decreased |
|---|---|---|---|---|---|---|
| 2024-06-30 | 17 | 89347 | 0.46% | 7 | 1 | 3 |
| 2024-03-31 | 9 | 32995 | 0.17% | 9 | 0 | 0 |
| date | orgName | total | ratio | changeShares | changeRatio |
|---|---|---|---|---|---|
| 2024-03-31 | Geode Capital Management, Llc | 20683 | 0.11% | 20683 | |
| 2024-03-31 | Pnc Financial Services Group, Inc. | 5000 | 0.03% | 5000 | |
| 2024-03-31 | Blackrock Inc. | 4433 | 0.02% | 4433 | |
| 2024-03-31 | Tower Research Capital Llc (Trc) | 1508 | 0.01% | 1508 | |
| 2024-03-31 | Royal Bank Of Canada | 1000 | 0.01% | 1000 | |
| 2024-03-31 | Global Retirement Partners, Llc | 200 | 0.00% | 200 | |
| 2024-03-31 | National Bank Of Canada /Fi/ | 150 | 0.00% | 150 | |
| 2024-03-31 | Wells Fargo & Company/Mn | 17 | 0.00% | 17 | |
| 2024-03-31 | Jpmorgan Chase & Co | 4 | 4 |
About
Autonomix Medical, Inc. is a development stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. Its technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies. The company was founded by Robert Schwartz, Landy Toth, David A. Robins, and Robert A. Van Tassel on June 10, 2014 and is headquartered in Doylestown, PA.
Address:21 Waterway Avenue,Suite 300
Website:http://www.autonomixmed.com
Market Movers